Design, synthesis, and antineoplastic activity of 2'-deoxy-2'-methylidenecytidine. 1988

K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

UI MeSH Term Description Entries
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
June 2000, Clinical pharmacokinetics,
K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
May 1991, Cancer research,
K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
April 2007, Bioorganic & medicinal chemistry letters,
K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
October 1996, Biological & pharmaceutical bulletin,
K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
November 2000, European journal of clinical pharmacology,
K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
January 1992, Anticancer research,
K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
October 2007, The Journal of toxicological sciences,
K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
June 2000, Clinical cancer research : an official journal of the American Association for Cancer Research,
K Takenuki, and A Matsuda, and T Ueda, and T Sasaki, and A Fujii, and K Yamagami
May 1986, Journal of medicinal chemistry,
Copied contents to your clipboard!